157 related articles for article (PubMed ID: 31550809)
1. [Genetic characteristics and clinical outcomes of pediatric acute myeloid leukemia with NUP98-NSD1 fusion gene].
Wang T; Ni JB; Wang XY; Dai Y; Ma XL; Su YC; Gao YY; Chen X; Yuan LL; Liu HX
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2820-2825. PubMed ID: 31550809
[No Abstract] [Full Text] [Related]
2. Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
Miyajima T; Onozawa M; Yoshida S; Miyashita N; Kimura H; Takahashi S; Yokoyama S; Matsukawa T; Goto H; Sugita J; Fujisawa S; Hidaka D; Ogasawara R; Mori A; Matsuoka S; Shigematsu A; Wakasa K; Kasahara I; Saga T; Hashiguchi J; Takeda Y; Ibata M; Yutaka T; Fujimoto K; Kondo T; Teshima T
Eur J Haematol; 2023 Oct; 111(4):620-627. PubMed ID: 37465857
[TBL] [Abstract][Full Text] [Related]
3. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.
Thanasopoulou A; Tzankov A; Schwaller J
Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of monitoring NUP98::NSD1 fusion genes before and after allogeneic hematopoietic stem cell transplantation].
Shang YK; Pan XA; Chang YJ; Qin YQ; Wang Y; Yan CH; Sun YQ; Huang XJ; Zhao XS
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1010-1015. PubMed ID: 38503524
[No Abstract] [Full Text] [Related]
5. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib and navitoclax act synergistically to target NUP98-NSD1
Kivioja JL; Thanasopoulou A; Kumar A; Kontro M; Yadav B; Majumder MM; Javarappa KK; Eldfors S; Schwaller J; Porkka K; Heckman CA
Leukemia; 2019 Jun; 33(6):1360-1372. PubMed ID: 30568173
[TBL] [Abstract][Full Text] [Related]
7. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract][Full Text] [Related]
8. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
9. [Molecular Characteristics and Clinical Features of Adults with
Lun Y; Huang JC; Long D; Wang FF; Dai Y; Yang Y; Zhao TT; Li Q; Wu Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):575-581. PubMed ID: 30378313
[TBL] [Abstract][Full Text] [Related]
10. Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
Shimada A; Iijima-Yamashita Y; Tawa A; Tomizawa D; Yamada M; Norio S; Watanabe T; Taga T; Iwamoto S; Terui K; Moritake H; Kinoshita A; Takahashi H; Nakayama H; Koh K; Goto H; Kosaka Y; Saito AM; Kiyokawa N; Horibe K; Hara Y; Oki K; Hayashi Y; Tanaka S; Adachi S
Int J Hematol; 2018 May; 107(5):586-595. PubMed ID: 29330746
[TBL] [Abstract][Full Text] [Related]
11. Rare NUP98::PRRX1 fusion transcript in a therapy-related acute myeloid leukemia associated with del(7q) following chemotherapy for diffuse large B-cell lymphoma.
Wang Y; Zhang Z; Wang L; Wang H; Dong F
Cancer Genet; 2024 Jun; 284-285():12-15. PubMed ID: 38493578
[TBL] [Abstract][Full Text] [Related]
12. NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Ostronoff F; Othus M; Gerbing RB; Loken MR; Raimondi SC; Hirsch BA; Lange BJ; Petersdorf S; Radich J; Appelbaum FR; Gamis AS; Alonzo TA; Meshinchi S
Blood; 2014 Oct; 124(15):2400-7. PubMed ID: 25145343
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.
Mitani Y; Hiwatari M; Seki M; Hangai M; Takita J
Int J Hematol; 2019 Oct; 110(4):512-516. PubMed ID: 31134509
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognosis of
Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
[TBL] [Abstract][Full Text] [Related]
15. Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia.
Kivioja JL; Lopez Martí JM; Kumar A; Kontro M; Edgren H; Parsons A; Lundán T; Wolf M; Porkka K; Heckman CA
Leuk Lymphoma; 2018 Mar; 59(3):725-732. PubMed ID: 28776436
[TBL] [Abstract][Full Text] [Related]
16. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
[TBL] [Abstract][Full Text] [Related]
17. Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.
Mohanty S; Jyotsana N; Sharma A; Kloos A; Gabdoulline R; Othman B; Lai CK; Schottmann R; Mandhania M; Schmoellerl J; Grebien F; Ramsay E; Thomas A; Vornlocher HP; Ganser A; Thol F; Heuser M
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32993115
[TBL] [Abstract][Full Text] [Related]
18. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
[TBL] [Abstract][Full Text] [Related]
19. Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.
Ganapathi SS; Raikar SS; Yatsenko SA; Djokic M; Bukowinski A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1372. PubMed ID: 33784031
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive molecular and clinical characterization of
Bertrums EJM; Smith JL; Harmon L; Ries RE; Wang YJ; Alonzo TA; Menssen AJ; Chisholm KM; Leonti AR; Tarlock K; Ostronoff F; Pogosova-Agadjanyan EL; Kaspers GJL; Hasle H; Dworzak M; Walter C; Muhlegger N; Morerio C; Pardo L; Hirsch B; Raimondi S; Cooper TM; Aplenc R; Gamis AS; Kolb EA; Farrar JE; Stirewalt D; Ma X; Shaw TI; Furlan SN; Brodersen LE; Loken MR; Van den Heuvel-Eibrink MM; Zwaan CM; Triche TJ; Goemans BF; Meshinchi S
Haematologica; 2023 Aug; 108(8):2044-2058. PubMed ID: 36815378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]